Clinical Microbiology & Infection

Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among <i>Escherichia coli</i> isolates from men with pyelonephritis or cystitis and healthy controls
pp. E173-E180(8)
Authors: Kudinha, T.; Johnson, J. R.; Andrew, S. D.; Kong, F.; Anderson, P.; Gilbert, G. L.; Tassies, P.

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization
pp. E181-E189(9)
Authors: Cheah, A. L. Y.; Spelman, T.; Liew, D.; Peel, T.; Howden, B. P.; Spelman, D.; Grayson, M. L.; Nation, R. L.; Kong, D. C. M.; Pappas, G.

Gastrointestinal colonization by KPC-producing <i>Klebsiella pneumoniae</i> following hospital discharge: duration of carriage and risk factors for persistent carriage
pp. E190-E196(7)
Authors: Feldman, N.; Adler, A.; Molshatzki, N.; Navon-Venezia, S.; Khabra, E.; Cohen, D.; Carmeli, Y.; Cantón, R.

Performance of two <i>Aspergillus </i>IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis
pp. E197-E204(8)
Authors: Baxter, C. G.; Denning, D. W.; Jones, A. M.; Todd, A.; Moore, C. B.; Richardson, M. D.; Roilides, E.

Fast and specific dermatophyte detection by automated DNA extraction and real-time PCR
pp. E205-E211(7)
Authors: Bergman, A.; Heimer, D.; Kondori, N.; Enroth, H.; Bottieau, E.

The increased incidence of <i>Mycoplasma pneumoniae</i> in France in 2011 was polyclonal, mainly involving <i>M. pneumoniae</i> type 1 strains
pp. E212-E217(6)
Authors: Pereyre, S.; Touati, A.; Petitjean-Lecherbonnier, J.; Charron, A.; Vabret, A.; Bébéar, C.; Greub, G.

Candidaemia in Sweden: a nationwide prospective observational survey
pp. E218-E221(4)
Authors: Ericsson, J.; Chryssanthou, E.; Klingspor, L.; Johansson, A. G.; Ljungman, P.; Svensson, E.; Sjölin, J.; Roilides, E.

It is about time physicians and clinical microbiologists in infectious diseases investigated the aetiology of obesity
pp. 303-304(2)
Author: Raoult, D.

Gut bacterial microbiota and obesity
pp. 305-313(9)
Authors: Million, M.; Lagier, J.-C.; Yahav, D.; Paul, M.

Microbes and obesity-interrelationship between infection, adipose tissue and the immune system
pp. 314-320(7)
Authors: Hegde, V.; Dhurandhar, N. V.

Overview of differences between microbial feed additives and probiotics for food regarding regulation, growth promotion effects and health properties and consequences for extrapolation of farm animal results to humans
pp. 321-330(10)
Authors: Bernardeau, M.; Vernoux, J.-P.

Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?
pp. 331-337(7)
Authors: Knaapen, M.; Kootte, R. S.; Zoetendal, E. G.; Vos, W. M.; Dallinga-Thie, G. M.; Levi, M.; Stroes, E. S.; Nieuwdorp, M.

Gut microbiota and non-alcoholic fatty liver disease: new insights
pp. 338-348(11)
Authors: Aron-Wisnewsky, J.; Gaborit, B.; Dutour, A.; Clement, K.

<i>Klebsiella pneumoniae</i> resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258
pp. 349-355(7)
Authors: Breurec, S.; Guessennd, N.; Timinouni, M.; Le, T. A. H.; Cao, V.; Ngandjio, A.; Randrianirina, F.; Thiberge, J. M.; Kinana, A.; Dufougeray, A.; Perrier-Gros-Claude, J. D.; Boisier, P.; Garin, B.; Brisse, S.

Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in <i>Escherichia coli</i>: 20 years of surveillance in resource-limited settings from Latin America
pp. 356-361(6)
Authors: Bartoloni, A.; Pallecchi, L.; Riccobono, E.; Mantella, A.; Magnelli, D.; Di Maggio, T.; Villagran, A. L.; Lara, Y.; Saavedra, C.; Strohmeyer, M.; Bartalesi, F.; Trigoso, C.; Rossolini, G. M.

Online-Only Abstracts
pp. 362-362(1)

A care bundle approach for prevention of ventilator-associated pneumonia
pp. 363-369(7)
Authors: Rello, J.; Afonso, E.; Lisboa, T.; Ricart, M.; Balsera, B.; Rovira, A.; Valles, J.; Diaz, E.; FADO Project Investigatorscr9,

Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials
pp. 370-378(9)
Authors: Skalsky, K.; Yahav, D.; Lador, A.; Eliakim-Raz, N.; Leibovici, L.; Paul, M.

Usefulness of antimicrobial susceptibility in the eradication of <i>Helicobacter pylori</i>
pp. 379-383(5)
Authors: Cosme, A.; Montes, M.; Martos, M.; Gil, I.; Mendarte, U.; Salicio, Y.; Piñeiro, L.; Recasens, M. T.; Ibarra, B.; Sarasqueta, C.; Bujanda, L.

Online-Only Abstracts
pp. 384-384(1)

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia
pp. 385-391(7)
Authors: Burgos, J.; Falcó, V.; Borrego, A.; Sordé, R.; Larrosa, M. N.; Martinez, X.; Planes, A. M.; Sánchez, A.; Palomar, M.; Rello, J.; Pahissa, A.

Online-Only Abstracts
pp. 392-392(1)

Online-Only Abstracts
pp. 393-394(2)

Online-Only Abstracts
pp. 395-396(2)